Donoghue Forlines’s CVS Health CVS Stock Holding History

Donoghue Forlines’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58M	Buy	21,992 +3,161	+17%	+$244K	0.44%	94
2025 Q4	$1.49M	Sell	18,831 -1,283	-6%	-$101K	0.46%	76
2025 Q3	$1.52M	Sell	20,114 -2,304	-10%	-$158K	0.47%	76
2025 Q2	$1.55M	Sell	22,418 -25	-0.1%	-$1.64K	0.44%	67
2025 Q1	$1.52M	Sell	22,443 -8,744	-28%	-$523K	0.48%	70
2024 Q4	$1.4M	Buy	+31,187	New	+$1.75M	0.47%	98
2022 Q3	–	Sell	-5,416	Closed	-$502K	–	248
2022 Q2	$502K	Sell	5,416 -5,038	-48%	-$492K	0.13%	220
2022 Q1	$1.06M	Sell	10,454 -1,660	-14%	-$174K	0.23%	123
2021 Q4	$1.25M	Buy	+12,114	New	+$1.12M	0.21%	92
2021 Q3	–	Sell	-13,670	Closed	-$1.14M	–	210
2021 Q2	$1.14M	Sell	13,670 -3,095	-18%	-$253K	0.21%	115
2021 Q1	$1.26M	Buy	+16,765	New	+$1.22M	0.24%	101

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Donoghue Forlines's CVS Position: Q1 2026 in Review

Donoghue Forlines increased its CVS Health (CVS) stake by 17% in Q1 2026, buying an estimated $244K and bringing the position to 21,992 shares worth $1.58M. The position accounts for 0.44% of the portfolio, ranked #94.

Donoghue Forlines first reported a position in CVS in Q1 2021 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Donoghue Forlines held 21,992 shares of CVS Health worth $1.58M as of Q1 2026.
Donoghue Forlines bought 3,161 CVS Health shares in Q1 2026, an estimated $244K.
CVS Health made up 0.44% of Donoghue Forlines's portfolio in Q1 2026, its #94 holding.
Donoghue Forlines first reported a position in CVS Health in Q1 2021 and has held it in 11 quarters since.
1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Donoghue Forlines's 13F filing for Q1 2026, filed 13 May 2026.